2017 Sep 21
How A Liquid Biopsy Changes Cancer Treatment
David Nanus, M.D., and Scott Tagawa, M.D., M.S., speak to Fox 5 News about liquid biopsies in cancer treatment. Read more
2017 Sep 21
Metastatic Breast Cancer Affects Bone Mineral Before Spreading
This article by Tom Fleischman first appeared in the Cornell Chronicle . When breast cancer metastasizes, or spreads, one of its most likely destinations is bone. In fact, four in five metastatic breast cancer patients will... Read more
2017 Sep 19
Phase II Study of Additional Treatment in Patients With Non-Hodgkin Lymphoma Shows No Significant Benefit
A phase II trial reported in the Journal of Clinical Oncolo gy by John P. Leonard, M.D., and collaborators showed no significant progression-free survival benefit of adding bortezomib to R-CHOP. Read more
2017 Sep 18
Epigenetic Code Plays a Role in Acute Myeloid Leukemia
This article by Bridget Kuehn first appeared in the Cornell Chronicle . Errors in the regulation of gene expression may contribute to the development of a common form of blood cancer and point to potential treatment... Read more
2017 Sep 15
Olivier Elemento, PhD, Appointed Director of the Englander Institute for Precision Medicine
Dr. Olivier Elemento , a renowned computational biologist and leader in the field of computational genomics and biomedicine, has been named director of the Caryl and Israel Englander Institute for Precision Medicine at Weill... Read more
2017 Sep 15
Double Targeting Ligands to Identify and Treat Prostate Cancer
John Babich, PhD, and collaborators have demonstrated a new way to identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. Read the featured basic article of the September... Read more
2017 Sep 07
Meyer Cancer Center Investigators Awarded $11.3 Million Prestigious Grant for Prostate Cancer Research
The Weill Cornell Medicine Specialized Programs of Research Excellence (SPORE) in Prostate Cancer, led by Mark Rubin, M.D., has been funded by the National Cancer Institute (NCI). Read more
2017 Aug 31
The most important lesson I learned from a patient: Optimism Leads to Achievement
Brendon Stiles, M.D., reflects on his experience with an inspiring young patient. Read more
2017 Aug 30
Impact of the FDA Approval of CTL019 in ALL
Gail J. Roboz, M.D., discusses the impact of the FDA approval of tisagenlecleucel (CTL019; Kymriah) in select pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL). Read more
2017 Aug 30
Drug may curb female infertility from cancer treatments
An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a study by Ithaca member John Schimenti, Ph.D. Read more
2017 Aug 29
The next steps for biopsies in prostate cancer
Jim Hu, M.D., MPH, discusses the next steps of biopsies for patients with prostate cancer. Read more
2017 Aug 28
Retinoids’ Extraordinary Potential
Feature about Lorraine Gudas, Ph.D., who is studying the role of Vitamin A and retinoic acid in cancer and other diseases. Read more
2017 Aug 25
Symposium addresses role of truth in universities, society
Holly Prigerson, Ph.D., spoke about the role of truth in their fields and in society during an academic symposium to celebrate the inauguration of Cornell's 14th president, Martha E. Pollack. Read more
2017 Aug 25
Immunotherapy gains traction as potential malignant pleural mesothelioma treatment
Ashish Saxena, M.D., Ph.D., comments on the results of a study on the use of immunotherapy to treat patients with the lung cancer mesothelioma. Read more
2017 Aug 25
Evolving paradigms in AML treatment
Gail Roboz, M.D., discusses evolving paradigms in treatment of patients with acute myeloid leukemia (AML). Read more
2017 Aug 24
Precision medicine in hematologic malignancies
John P. Leonard, M.D., discusses the advance of precision medicine across hematologic malignancies. Read more
2017 Aug 24
Early stage kidney cancer treatment
David M. Nanus, M.D., discusses treatment for patients with early-stage kidney cancer. Read more
2017 Aug 23
A million dollars in Movember money funds advanced prostate cancer research
Meyer prostate cancer experts led by Scott Tagawa, M.D., will use Movember funds to investigate a new treatment for an advanced form of the disease. Read more
2017 Aug 23
Research trial in NYC may change course of brain tumor treatment
Howard Fine, M.D., is determined to change the course of glioblastoma treatment, by testing drugs on 'mini brains' created in the lab. Read more
2017 Aug 18
Potential of immunotherapy in MCL landscape
Peter Martin, M.D., discusses the potential of modern immunotherapies in the landscape of mantle cell lymphoma (MCL). Read more
